Lansoprazole Capsule, Delayed Release
Product Images NDC 71335-1425

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Lansoprazole (NDC 71335-1425). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

F53ca2be-a290-4157-ad95-d24dfe3344f9-01 (F53ca2be A290 4157 Ad95 D24dfe3344f9 01)

Chemical structure of the active ingredient lansoprazole, showing its molecular framework with heterocyclic rings, sulfoxide group, and trifluoromethoxy substituent.*

FDA Label Image

F53ca2be-a290-4157-ad95-d24dfe3344f9-02 (F53ca2be A290 4157 Ad95 D24dfe3344f9 02)

A line graph titled 'Mean Severity of Day Heartburn By Study Day For Evaluable Patients' showing severity scores (0 to 3) on the y-axis versus days from start of treatment on the x-axis. It compares placebo, Lansoprazole 15 mg QD, and Lansoprazole 30 mg QD groups over approximately 60 days, illustrating reductions in heartburn severity for the lansoprazole groups compared to placebo.*

FDA Label Image

F53ca2be-a290-4157-ad95-d24dfe3344f9-03 (F53ca2be A290 4157 Ad95 D24dfe3344f9 03)

A line graph showing mean severity of night heartburn over days from start of treatment in evaluable patients. The y-axis measures mean severity from 0 (none) to 3 (severe), and the x-axis shows days from -5 to 60. Three treatments are compared: placebo, Lansoprazole 15 mg QD, and Lansoprazole 30 mg QD. Both Lansoprazole doses show a rapid decrease in heartburn severity after treatment begins, with 30 mg showing the greatest reduction.*

FDA Label Image

F53ca2be-a290-4157-ad95-d24dfe3344f9-06 (F53ca2be A290 4157 Ad95 D24dfe3344f9 1)

Lansoprazole 30 mg delayed-release capsules packaging from Bryant Ranch Prepack. The label shows the proprietary name Lansoprazole, strength 30 mg, and dosage form as oral capsules. The label is predominantly white with green accents and includes the Lifestar logo. The package is designed for prescription use.*

FDA Label Image

F53ca2be-a290-4157-ad95-d24dfe3344f9-07 (F53ca2be A290 4157 Ad95 D24dfe3344f9 2)

Lansoprazole 30 mg delayed-release capsules label by Bryant Ranch Prepack. The label shows the proprietary and generic name, capsule dosage form, strength (30 mg), and product NDC 71335-1425. It is an oral prescription drug with the labeler name and NDC code clearly displayed on the packaging.*

FDA Label Image

Label Image (Lbl713351425)

Lansoprazole DR 30 mg delayed-release capsule label from Bryant Ranch Prepack. The label includes the generic name Lansoprazole, dosage strength 30 mg, and packaging details indicating a quantity of 30 capsules. It states comparison to Prevacid 30 mg capsule and storage instructions to keep at room temperature (20°-25°C). The label also features a barcode and the NDC 71335-1425-1.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.